Article ; Online: Radiolabeled gemcitabine hydrochloride as an imaging agent for lung cancer: Radiolabeling, quality control and cell incorporation studies.
2023 Volume 198, Page(s) 110856
Abstract: The development of new drugs that can specifically screen tumors is a global need. When it comes to lung cancer, which is the second main cause of cancer-related deaths, early detection of lung tumors using appropriate imaging is very important. In this ... ...
Abstract | The development of new drugs that can specifically screen tumors is a global need. When it comes to lung cancer, which is the second main cause of cancer-related deaths, early detection of lung tumors using appropriate imaging is very important. In this study, gemcitabine hydrochloride (GCH) was radiolabeled with [ |
---|---|
MeSH term(s) | Humans ; Technetium/chemistry ; Gemcitabine ; Antioxidants ; Reducing Agents ; Radiopharmaceuticals/chemistry ; Lung Neoplasms/diagnostic imaging ; Quality Control |
Chemical Substances | Technetium (7440-26-8) ; Gemcitabine ; Antioxidants ; Reducing Agents ; Radiopharmaceuticals |
Language | English |
Publishing date | 2023-05-23 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 1142596-9 |
ISSN | 1872-9800 ; 0883-2889 ; 0969-8043 |
ISSN (online) | 1872-9800 |
ISSN | 0883-2889 ; 0969-8043 |
DOI | 10.1016/j.apradiso.2023.110856 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ue I Zs.279: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.